Note 8 - Share-based Compensation |
9 Months Ended |
|---|---|
Mar. 31, 2017 | |
| Notes to Financial Statements | |
| Disclosure of Compensation Related Costs, Share-based Payments [Text Block] |
Note 8. Share-based Compensation:During the
nine months ended March 31, 2017 and 2016, the Company granted 1
.1 million and 804,000 stock options at weighted average grant prices of $107
.38 and $105
.15 and weighted average fair values of $18
.13 and $18.50, respectively. During the nine months ended March 31, 2017 and 2016, the Company granted 64
,931 and 35,000 restricted stock units at a weighted average fair value of $109
.36 and $105.01, respectively. During the nine months ended March 31, 2017 and 2016, the Company granted 23
,965 and 20,000 shares of restricted stock at grant date fair values of $104
.94 and $99.53, respectively.
Stock options for
39
,579 and 18,000 shares of common stock with total intrinsic values of $1
.4 million and $0.6 million were exercised during the nine months ended March 31, 2017 and 2016, respectively.Stock-based compensation expense of
$4
.0 million and $2
.3 million was included in selling, general and administrative expenses for the quarter ended March 31, 2017 and 2016, respectively. Stock-based compensation expense of $11
.2 million and $6.7 million was included in selling, general and administrative expenses for the nine months ended March 31, 2017 and 2016, respectively. As of March 31, 2017, there was $29
.4 million of unrecognized compensation cost related to non-vested stock options, non-vested restricted stock units and non-vested restricted stock. The weighted average period over which the compensation cost is expected to be recognized is 2.5 years. |